Michael S. Feldman

Michael S. Feldman

Corporate Officer/Principal chez University of London

Consumer Services
Health Technology
Commercial Services

Profil

Michael S.
Feldman
is currently a Principal at the University of London.
Previously, he held positions as Director at BioMicro Systems, Inc., Vice President-Business Development at LabOne, Inc., and General Manager at Northwest Toxicology.
He also held Principal positions at Quest Diagnostics, SmithKline Beecham Clinical Laboratories, Roche Biomedical Laboratories, Inc., and Roche Diagnostic Systems, Inc. Feldman received a graduate degree from Drexel University, an undergraduate degree from Rutgers State University of New Jersey, and a doctorate degree from The University of the Arts London.

Postes actifs de Michael S. Feldman

SociétésPosteDébut
University of London Corporate Officer/Principal -
Tous les postes actifs de Michael S. Feldman

Anciens postes connus de Michael S. Feldman

SociétésPosteFin
President 12/11/2009
Corporate Officer/Principal -
Roche Biomedical Laboratories, Inc. Corporate Officer/Principal -
Corporate Officer/Principal -
QUEST DIAGNOSTICS INCORPORATED Corporate Officer/Principal -
Voir l'expérience en détail de Michael S. Feldman

Formation de Michael S. Feldman

Drexel University Graduate Degree
Rutgers State University of New Jersey Undergraduate Degree
The University of the Arts London Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Michael S. Feldman

Relations

28

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
QUEST DIAGNOSTICS INCORPORATED

Health Services

Entreprise privées6

Commercial Services

Health Technology

Commercial Services

Roche Biomedical Laboratories, Inc.

Health Technology

Commercial Services

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Michael S. Feldman
-40% Prolongation exceptionnelle : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT